Saturday 17 October 2026
Export POCI’s income statement to Excel — free account
Precision Optics Corp.
POCI Healthcare Medical Instruments & Supplies
Precision Optics Corp.’s revenue for fiscal 2026 (year ended June 2026) was $31.5 million, up 65.2% from fiscal 2025. In the quarter to June 2026, revenue grew 42.0%, EPS grew 117.4%, free cash flow fell 45.6% and total debt fell 31.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.26
0.09
−2.07%
Follow POCI
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | 2 | 5 | 0 | 5 | 3 | 3 | 6 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
0.59 | (1.10) | (0.34) | 0.54 | (0.83) | (4.15) | (6.05) | (5.54) | (22.11) | (32.08) |
P/S ratio |
1.38 | 1.74 | 1.98 | 1.66 | 1.99 | 2.09 | 1.90 | 1.92 | 1.29 | 1.59 |
Altman Z″-Score (non-manufacturers) |
(2.77) | (8.27) | (8.55) | (5.01) | (8.02) | (21.88) | (22.99) | (17.13) | (57.81) | (82.39) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 95.20 | 0.00 |
Beneish M-Score |
(2.28) | (2.51) | (2.50) | (2.26) | (0.86) | (2.27) | (3.16) | 1.24 | (2.91) | (3.55) |
P/Operating CF |
(67.03) | (79.69) | (38.73) | (57.36) | (584.70) | 182.87 | (37.09) | (168.72) | 25.10 | (141.00) |
P/B ratio |
2.14 | 2.71 | 3.75 | 2.89 | 3.48 | 6.50 | 6.80 | 3.88 | 9.23 | 8.96 |
Price to Tangible BV |
3.85 | 10.39 | 39.50 | 11.78 | 0.00 | 8.58 | 9.48 | 4.97 | 10.08 | 9.47 |
EV/Sales |
1.11 | 1.75 | 2.13 | 1.65 | 2.11 | 2.02 | 1.79 | 1.59 | 1.19 | 1.56 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(22.55) | (9.83) | (15.13) | (427.59) | (35.42) | 463.54 | (29.95) | (10.48) | 47.86 | (7.36) |
EV/FCF |
(17.66) | (9.19) | (13.64) | (259.56) | (30.44) | (284.97) | (23.58) | (9.17) | 88.10 | (7.01) |
Quick Ratio |
1.79 | 0.99 | 0.81 | 1.30 | 0.71 | 1.09 | 0.83 | 1.23 | 0.62 | 0.48 |
Current Ratio |
2.28 | 1.64 | 1.45 | 1.87 | 1.42 | 1.90 | 1.57 | 1.76 | 1.25 | 1.39 |
Net Debt/EBITDA |
2.65 | (0.02) | (1.11) | 0.39 | (1.39) | 0.80 | 0.14 | 3.96 | 1.21 | 0.10 |
Debt/Assets |
3.99% | 9.43% | 18.94% | 13.97% | 14.61% | 4.02% | 15.02% | 0.19% | 0.58% | 1.31% |
Debt/Equity |
0.06 | 0.15 | 0.32 | 0.23 | 0.27 | 0.07 | 0.34 | 0.00 | 0.03 | 0.04 |
Asset Turnover |
1.21 | 1.04 | 1.04 | 1.15 | 1.37 | 1.69 | 1.43 | 1.36 | 1.87 | 1.61 |
Operating CF/Net income |
0.43 | 0.59 | 0.91 | 0.56 | 1.01 | (0.45) | 0.42 | 1.68 | (0.29) | 0.66 |
Capex/Depreciation |
(1.54) | (1.10) | (1.38) | (0.25) | (0.80) | (0.83) | (1.43) | (3.80) | (0.79) | (0.99) |
Interest Coverage |
(23.69) | (24.46) | (12.10) | (2.92) | (9.72) | (170.87) | (1,423.00) | (437.50) | (183.47) | (323.35) |
| (22.26%) | (51.78%) | (26.69%) | (1.38%) | (14.97%) | (3.31%) | (46.39%) | (31.21%) | (62.62%) | (175.72%) | |
| (13.93%) | (31.50%) | (16.10%) | (0.79%) | (8.09%) | (1.63%) | (20.60%) | (12.29%) | (16.30%) | (51.30%) | |
ROIC |
(18.59%) | (28.09%) | (13.23%) | (3.36%) | (8.76%) | (20.06%) | (34.33%) | (34.70%) | (123.86%) | (135.14%) |
Return on Tangible Assets |
(29.83%) | (130.17%) | (109.11%) | (2.87%) | (36.46%) | (3.59%) | (61.98%) | (19.58%) | (66.13%) | (182.37%) |
Average Days of Receivables |
68.81 | 82.91 | 67.74 | 67.77 | 62.02 | 64.24 | 54.49 | 116.14 | 72.03 | 54.21 |
Research and Development Expense of Revenue |
3.28% | 6.07% | 5.14% | 4.72% | 4.25% | 5.85% | 8.93% | 7.43% | 11.30% | 14.72% |
Selling, General and Administrative Expense of Revenue |
25.08% | 40.84% | 39.47% | 35.07% | 35.80% | 34.80% | 39.29% | 30.89% | 34.03% | 41.64% |
Intangible Assets out of Total Assets |
0.28 | 0.46 | 0.54 | 0.46 | 0.54 | 0.13 | 0.12 | 0.10 | 0.02 | 0.02 |
Share Based Compensation of Revenue |
3.61% | 8.44% | 5.02% | 4.37% | 5.84% | 6.88% | 5.06% | 3.87% | 1.30% | 6.39% |
Graham Net Nets |
0.19 | 0.08 | 0.01 | 0.06 | (0.04) | 0.09 | 0.07 | 0.17 | 0.09 | 0.09 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(8.28%) | (17.14%) | (7.87%) | (0.13%) | (1.57%) | (0.59%) | (7.36%) | (4.97%) | (7.40%) | (21.67%) |
Free Cash Flow Yield |
(4.55%) | (10.91%) | (7.87%) | (0.38%) | (3.48%) | (0.34%) | (3.99%) | (9.00%) | 1.05% | (14.00%) |
Revenue per Share |
3.70 | 2.81 | 3.15 | 3.71 | 3.00 | 2.41 | 2.29 | 1.78 | 1.23 | 1.13 |
Operating CF per Share |
(0.18) | (0.50) | (0.44) | (0.01) | (0.18) | 0.01 | (0.14) | (0.27) | 0.03 | (0.24) |
Capex per Share |
(0.05) | (0.03) | (0.05) | (0.01) | (0.03) | (0.03) | (0.04) | (0.04) | (0.01) | (0.01) |
Free Cash Flow per Share |
(0.23) | (0.53) | (0.49) | (0.02) | (0.21) | (0.02) | (0.17) | (0.31) | 0.02 | (0.25) |
Cash per Share |
1.15 | 0.26 | 0.07 | 0.52 | 0.12 | 0.19 | 0.26 | 0.60 | 0.12 | 0.04 |
Shareholders Equity per Share |
2.39 | 1.81 | 1.66 | 2.13 | 1.72 | 0.78 | 0.64 | 0.88 | 0.17 | 0.20 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.39 | 1.81 | 1.66 | 2.13 | 1.72 | 0.78 | 0.64 | 0.88 | 0.17 | 0.20 |
Free Cash Flow |
(1.98) | (3.63) | (2.98) | (0.13) | (1.09) | (0.08) | (0.75) | (1.18) | 0.08 | (0.70) |
Working Capital |
11.28 | 3.91 | 2.21 | 4.60 | 1.92 | 2.27 | 1.80 | 2.76 | 0.48 | 0.48 |
Capital Expenditures |
(0.43) | (0.23) | (0.29) | (0.05) | (0.15) | (0.12) | (0.16) | (0.15) | (0.02) | (0.03) |
Net Current Asset Value |
8.12 | 2.53 | 0.27 | 2.17 | (1.23) | 1.95 | 1.37 | 2.25 | 0.47 | 0.46 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.31 | 0.40 | 0.43 | 0.49 | 0.30 | 0.25 | 0.22 | 0.10 | 0.55 | 0.47 |
Cash ROIC |
(6.29%) | (22.83%) | (21.77%) | (0.75%) | (9.04%) | (1.67%) | (15.49%) | (20.75%) | 8.06% | (100.06%) |
Accounts Receivable Turnover |
6.13 | 4.84 | 5.13 | 6.41 | 6.90 | 6.35 | 5.44 | 4.59 | 6.38 | 5.18 |
Accounts Payable Turnover |
8.04 | 7.29 | 6.95 | 5.70 | 6.24 | 6.38 | 5.86 | 4.99 | 3.66 | 2.58 |
Inventory Turnover |
7.06 | 4.88 | 4.72 | 4.59 | 4.38 | 3.55 | 3.34 | 3.25 | 2.32 | 2.18 |
Average Days of Payables |
50.10 | 67.69 | 38.33 | 66.70 | 76.03 | 60.74 | 59.31 | 91.55 | 100.46 | 106.55 |
Days of Inventory on Hand |
53.55 | 82.88 | 78.67 | 76.13 | 102.61 | 95.03 | 122.24 | 135.23 | 163.37 | 161.80 |
Average Receivables |
5.14 | 3.94 | 3.73 | 3.29 | 2.27 | 1.68 | 1.82 | 1.48 | 0.63 | 0.61 |
Average Payables |
3.25 | 2.15 | 1.91 | 2.34 | 1.72 | 1.14 | 1.12 | 0.94 | 0.70 | 0.92 |
Average Inventory |
3.70 | 3.22 | 2.82 | 2.90 | 2.45 | 2.04 | 1.97 | 1.44 | 1.10 | 1.09 |
Average Assets |
26.06 | 18.35 | 18.33 | 18.22 | 11.48 | 6.31 | 6.92 | 5.00 | 2.16 | 1.96 |
Average Common Equity |
16.30 | 11.16 | 11.06 | 10.51 | 6.20 | 3.10 | 3.07 | 1.97 | 0.56 | 0.57 |
Columns are period end dates · fundamentals updated 30 Sep 2026